Russell Investments Group
ACIU icon

Russell Investments Group’s AC Immune ACIU Stock Holding History

Russell Investments Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,652
Closed -$17K – 3173
2020
Q2 		$17K Hold
2,652
– – ﹤0.01% 3062
2020
Q1 		$19K Sell
2,652
-8,726
-77% -$68.2K ﹤0.01% 2955
2019
Q4 		$93K Buy
+11,378
New +$75.8K ﹤0.01% 2907
2019
Q3 		– Sell
-1,424
Closed -$8K – 3015
2019
Q2 		$8K Buy
+1,424
New +$7.26K ﹤0.01% 2823

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Russell Investments Group's ACIU Position: Q3 2020 in Review

Russell Investments Group sold out of AC Immune (ACIU) in Q3 2020, closing a stake of 2,652 shares — an estimated $17K sold.

Russell Investments Group first reported a position in ACIU in Q2 2019 and held it in 4 quarters. The position peaked at $93K in Q4 2019. 53 funds tracked by Wall St. Rank hold ACIU as of Q3 2020.

  • Russell Investments Group reported no remaining AC Immune position as of Q3 2020 after selling out during the quarter.
  • Russell Investments Group sold 2,652 AC Immune shares in Q3 2020, an estimated $17K.
  • Russell Investments Group first reported a position in AC Immune in Q2 2019 and held it in 4 quarters.
  • Russell Investments Group's AC Immune position peaked at $93K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held AC Immune as of Q3 2020.

Based on Russell Investments Group's 13F filing for Q3 2020, filed 9 Nov 2020.